Rosetta Genomics Ltd
OTC:ROSGQ

Watchlist Manager
Rosetta Genomics Ltd Logo
Rosetta Genomics Ltd
OTC:ROSGQ
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 6 USD
Have any thoughts about
Rosetta Genomics Ltd?
Write Note

Rosetta Genomics Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rosetta Genomics Ltd
Net Income Peer Comparison

Comparables:
CLGN
KMDA
B
BLRX
URGN
B
BONS

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Rosetta Genomics Ltd
OTC:ROSGQ
Net Income
-$16.2m
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Net Income
-$7m
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Net Income
$15.1m
CAGR 3-Years
-9%
CAGR 5-Years
3%
CAGR 10-Years
N/A
B
BioLine RX Ltd
TASE:BLRX
Net Income
-$49.1m
CAGR 3-Years
-14%
CAGR 5-Years
-16%
CAGR 10-Years
-12%
Urogen Pharma Ltd
NASDAQ:URGN
Net Income
-$113.6m
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Net Income
-â‚Ş29.2m
CAGR 3-Years
26%
CAGR 5-Years
-5%
CAGR 10-Years
-9%

See Also

What is Rosetta Genomics Ltd's Net Income?
Net Income
-16.2m USD

Based on the financial report for Dec 31, 2016, Rosetta Genomics Ltd's Net Income amounts to -16.2m USD.

What is Rosetta Genomics Ltd's Net Income growth rate?
Net Income CAGR 5Y
-10%

Over the last year, the Net Income growth was 6%. The average annual Net Income growth rates for Rosetta Genomics Ltd have been -8% over the past three years , -10% over the past five years .

Back to Top